DZ Bank
BIVV

DZ Bank’s Bioverativ Inc. Common Stock BIVV Stock Holding History

DZ Bank’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-50,640
Closed -$2.73M – 1194
2017
Q4 		$2.73M Sell
50,640
-205,686
-80% -$11.3M 0.01% 449
2017
Q3 		$14.6M Sell
256,326
-72,960
-22% -$4.27M 0.06% 225
2017
Q2 		$19.8M Buy
329,286
+7,668
+2% +$437K 0.09% 178
2017
Q1 		$17.5M Buy
+321,618
New +$15.8M 0.08% 191

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

DZ Bank's BIVV Position: Q1 2018 in Review

DZ Bank sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 50,640 shares — an estimated $2.73M sold.

DZ Bank first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $19.8M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • DZ Bank reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • DZ Bank sold 50,640 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $2.73M.
  • DZ Bank first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • DZ Bank's Bioverativ Inc. Common Stock position peaked at $19.8M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on DZ Bank's 13F filing for Q1 2018, filed 15 May 2018.